|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation & amortization | |||||
| Stock-based compensation expense | |||||
| Unrealized gain on non-marketable securities | |||||
| Loss (gain) on sales of assets and businesses | |||||
| Costs related to extinguishment of debt | |||||
| Provision for asset impairment | |||||
| Changes in assets & liabilities, net of effects from acquisitions and dispositions: | |||||
| Accounts receivable | |||||
| Accrued interest | |||||
| Accrued and deferred income taxes | |||||
| Other working capital accounts | |||||
| Other assets and deferred charges | |||||
| Other, net | |||||
| Accrued insurance expense, net of commercial premiums paid | |||||
| Payments made in settlement of self-insurance claims | |||||
| Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements | |||||
| Deferred grant revenue | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Property and equipment additions | |||||
| Proceeds received from sales of assets and businesses | |||||
| Costs incurred for purchase and implementation of information technology applications | |||||
| Acquisition of businesses and property | |||||
| (Outflows) inflows from foreign exchange contracts that hedge our net U.K. investment. | |||||
| Costs incurred for purchase and development of enterprise resource planning application | |||||
| Proceeds received from sale of marketable equity securities | |||||
| Investments in non-marketable securities | |||||
| Decrease in capital reserves of commercial insurance subsidiary | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Repayments of long-term debt | |||||
| Additional borrowings | |||||
| Financing costs | |||||
| Repurchase of common shares | |||||
| Dividends paid | |||||
| Issuance of common stock | |||||
| Profit distributions to noncontrolling interests | |||||
| Purchase of ownership interests by minority members | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Disclosures of Cash Flow Information: | |||||
| Interest paid | |||||
| Income taxes paid, net of refunds | |||||
| Noncash purchases of property and equipment | |||||
Loading...